{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:52:08Z","timestamp":1785855128913,"version":"3.56.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parathyroid hormone (PTH) is a key biochemical marker in the diagnosis and management of disorders of calcium\u2013phosphate metabolism. However, circulating PTH represents a heterogeneous mixture of full-length PTH(1-84) and multiple truncated fragments that differ in biological activity and clearance. These molecular forms are variably detected by commercially available immunoassays, resulting in assay-dependent differences in measured PTH concentrations. In endocrine surgery, intraoperative PTH monitoring (ioPTH) is widely used to assess the adequacy of parathyroidectomy based on the rapid decline of circulating PTH. This approach assumes that measured PTH concentrations reliably reflect biologically relevant hormone dynamics. However, accumulating evidence indicates that both assay characteristics and physiological factors may influence observed PTH kinetics. Most data on PTH immunoheterogeneity originate from studies in chronic kidney disease, where fragment accumulation is well documented. In contrast, the implications of PTH heterogeneity for intraoperative monitoring and broader clinical interpretation remain less clearly defined. This review summarizes current evidence on PTH molecular heterogeneity, assay-dependent variability, and systemic factors affecting PTH metabolism and discusses their implications for interpretation of PTH measurements in dynamic clinical settings. Recognition of these interactions may improve interpretation of laboratory results and support more accurate clinical decision-making in endocrine practice.<\/jats:p>","DOI":"10.1093\/ejendo\/lvag131","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:53:48Z","timestamp":1784807628000},"page":"R56-R64","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid hormone heterogeneity and assay-dependent interpretation in practice"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9566-3039","authenticated-orcid":false,"given":"Ewa","family":"Koz\u0142owska","sequence":"first","affiliation":[{"name":"Central Laboratory, University Clinical Center of Medical University of Warsaw , 02-097 Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-9159","authenticated-orcid":false,"given":"Witold","family":"Chudzi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of General, Vascular, Endocrine and Transplant Surgery, Medical University of Warsaw , 02-097 Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-4076","authenticated-orcid":false,"given":"Olga","family":"Ciepiela","sequence":"additional","affiliation":[{"name":"Central Laboratory, University Clinical Center of Medical University of Warsaw , 02-097 Warsaw ,","place":["Poland"]},{"name":"Department of Laboratory Medicine, Medical University of Warsaw , 02-097 Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"10","key":"2026080410030260300_lvag131-B1","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2026080410030260300_lvag131-B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cca.2005.10.010","article-title":"Practical considerations in PTH testing","volume":"366","author":"Souberbielle","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2026080410030260300_lvag131-B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0039-6060(03)00387-8","article-title":"Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism","volume":"135","author":"Yamashita","year":"2004","journal-title":"Surgery"},{"issue":"1","key":"2026080410030260300_lvag131-B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jss.2006.08.036","article-title":"Significance of monitoring bio-intact PTH (1\u201384) during parathyroidectomy for secondary hyperparathyroidism","volume":"139","author":"Ikeda","year":"2007","journal-title":"J Surg Res"},{"issue":"6","key":"2026080410030260300_lvag131-B5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1258\/000456305774538283","article-title":"Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery","volume":"42","author":"Phillips","year":"2005","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"2026080410030260300_lvag131-B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/CRD.0000000000000250","article-title":"Parathyroid hormone and cardiac electrophysiology: a review","volume":"27","author":"Palmeri","year":"2019","journal-title":"Cardiol Rev"},{"issue":"1","key":"2026080410030260300_lvag131-B7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40792-024-01903-z","article-title":"Intraoperative parathyroid hormone measurement pitfalls: parathyroid hormone spikes with carboxyl-terminal parathyroid hormone fragments in primary hyperparathyroidism\u2014a case report","volume":"10","author":"Yamashita","year":"2024","journal-title":"Surg Case Rep"},{"issue":"11","key":"2026080410030260300_lvag131-B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.96720","article-title":"Chasing the drop: miami versus dual criteria for intraoperative parathyroid hormone monitoring in primary hyperparathyroidism","volume":"17","author":"Rajamanickam","year":"2025","journal-title":"Cureus"},{"key":"2026080410030260300_lvag131-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101480","article-title":"Parathyroid hormone (PTH) regulation of metabolic homeostasis: an old dog teaches us new tricks","volume":"60","author":"Rendina-Ruedy","year":"2022","journal-title":"Mol Metab"},{"issue":"4","key":"2026080410030260300_lvag131-B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/proteomes12040030","article-title":"Multiple reaction monitoring\u2013mass spectrometric immunoassay analysis of parathyroid hormone fragments with vitamin D deficiency in patients with diabetes mellitus","volume":"12","author":"Benabdelkamel","year":"2024","journal-title":"Proteomes"},{"issue":"4","key":"2026080410030260300_lvag131-B11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"issue":"11","key":"2026080410030260300_lvag131-B12","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1210\/jcem.81.11.8923839","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026080410030260300_lvag131-B13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","article-title":"Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism","volume":"68","author":"D\u2019Amour","year":"2005","journal-title":"Kidney Int"},{"key":"2026080410030260300_lvag131-B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.vh.2022.03.001","article-title":"Structural pharmacology of PTH and PTHrP","volume":"120","author":"Suva","year":"2022","journal-title":"Vitam Horm"},{"issue":"5","key":"2026080410030260300_lvag131-B15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","article-title":"Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays","volume":"46","author":"Brossard","year":"2000","journal-title":"Clin Chem"},{"issue":"8","key":"2026080410030260300_lvag131-B16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1681\/ASN.2022010036","article-title":"High-resolution mass spectrometry for the measurement of PTH and PTH fragments: insights into PTH physiology and bioactivity","volume":"33","author":"Ulmer","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2026080410030260300_lvag131-B17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1515\/cclm-2022-0942","article-title":"Determination of parathyroid hormone: from radioimmunoassay to LCMS\/MS","volume":"61","author":"Cavalier","year":"2023","journal-title":"Clin Chem Lab Med."},{"issue":"2","key":"2026080410030260300_lvag131-B18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.kint.2023.09.033","article-title":"Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease","volume":"105","author":"Cavalier","year":"2024","journal-title":"Kidney Int"},{"key":"2026080410030260300_lvag131-B19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4939-3182-8_22","article-title":"Quantitation of parathyroid hormone in Serum or plasma by liquid chromatography-tandem mass spectrometry","volume":"1378","author":"Ketha","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2026080410030260300_lvag131-B20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/clinchem\/hvab013","article-title":"Chemical characterization and quantification of circulating intact PTH and PTH fragments by high-resolution mass spectrometry in chronic renal failure","volume":"67","author":"Kritmetapak","year":"2021","journal-title":"Clin Chem"},{"issue":"suppl 3","key":"2026080410030260300_lvag131-B21","doi-asserted-by":"publisher","first-page":"iii59","DOI":"10.1093\/ndtplus\/sfn089","article-title":"The whole-PTH\/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism","volume":"1","author":"Tanaka","year":"2008","journal-title":"NDT Plus"},{"issue":"suppl 3","key":"2026080410030260300_lvag131-B22","doi-asserted-by":"publisher","first-page":"iii54","DOI":"10.1093\/ndtplus\/sfn088","article-title":"Reversed whole PTH\/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review","volume":"1","author":"Komaba","year":"2008","journal-title":"NDT Plus"},{"issue":"1","key":"2026080410030260300_lvag131-B23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00423-025-03796-4","article-title":"Do stricter criteria for intraoperative parathyroid hormone monitoring reduce the risk of persistence or reoperation in primary hyperparathyroidism? A receiver operating characteristic analysis","volume":"410","author":"Wolf","year":"2025","journal-title":"Langenbecks Arch Surg"},{"key":"2026080410030260300_lvag131-B24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cca.2020.03.020","article-title":"Oxidation of parathyroid hormone","volume":"506","author":"Ursem","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1-2","key":"2026080410030260300_lvag131-B25","first-page":"21","article-title":"Evolution of the parathyroid hormone (PTH) assay\u2013importance of circulating PTH immunoheterogeneity and of its regulation","volume":"51","author":"Gao","year":"2005","journal-title":"Clin Lab"},{"issue":"1","key":"2026080410030260300_lvag131-B26","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v14i1.2700","article-title":"Comparison of second and third-generation parathyroid hormone assays at a tertiary hospital in South Africa","volume":"14","author":"Nhlapo","year":"2025","journal-title":"Afr J Lab Med"},{"issue":"s1","key":"2026080410030260300_lvag131-B27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1744-9987.2011.00926.x","article-title":"Comparison between whole and intact parathyroid hormone assays","volume":"15 Suppl 1","author":"Taniguchi","year":"2011","journal-title":"Ther Apher Dial"},{"issue":"4","key":"2026080410030260300_lvag131-B28","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1053\/ajkd.2001.27436","article-title":"Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients","volume":"38","author":"Nakanishi","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2026080410030260300_lvag131-B29","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1210\/er.2018-00220","article-title":"Clinical guidelines and PTH measurement: does assay generation matter?","volume":"40","author":"Smit","year":"2019","journal-title":"Endocr Rev"},{"key":"2026080410030260300_lvag131-B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1702206","article-title":"Parathyroid hormone assay standardization in CKD-MBD: resolving heterogeneity for precision medicine","volume":"16","author":"Bai","year":"2025","journal-title":"Front Endocrinol"},{"issue":"4","key":"2026080410030260300_lvag131-B31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3803\/EnM.2019.34.4.327","article-title":"Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism","volume":"34","author":"Khan","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2026080410030260300_lvag131-B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116678","article-title":"Quantification and clinical performance of serum parathyroid hormone 1\u201384 via immunocapture coupled to LC\u2013MS\/MS in chronic renal failure","volume":"256","author":"Cao","year":"2025","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"2026080410030260300_lvag131-B33","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026080410030260300_lvag131-B34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10157-014-1045-3","article-title":"Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy","volume":"19","author":"Koda","year":"2015","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2026080410030260300_lvag131-B35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1258\/0004563021902044","article-title":"Comparison of intact and \u201cwhole molecule\u201d parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy","volume":"39","author":"Godber","year":"2002","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"2026080410030260300_lvag131-B36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.kint.2023.11.020","article-title":"Standardization of PTH measurement by LC-MS\/MS: a promising solution for interassay variability","volume":"105","author":"Nakagawa","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"2026080410030260300_lvag131-B37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4103\/ijem.IJEM_678_17","article-title":"Intraoperative parathyroid hormone monitoring in guiding adequate parathyroidectomy","volume":"22","author":"Naik","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"2026080410030260300_lvag131-B38","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1245\/s10434-007-9590-6","article-title":"Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer","volume":"14","author":"Sol\u00f3rzano","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2026080410030260300_lvag131-B39","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1038\/s41598-022-07380-4","article-title":"Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism","volume":"12","author":"Graceffa","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2026080410030260300_lvag131-B40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/0886022X.2021.1931318","article-title":"Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients","volume":"43","author":"Chen","year":"2021","journal-title":"Ren Fail"},{"issue":"3","key":"2026080410030260300_lvag131-B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5604\/01.3001.0054.4440","article-title":"Do large parathyroid adenomas increase the risk of severe hypercalcemia?","volume":"96","author":"Kaszczewska","year":"2024","journal-title":"Pol J Surg"},{"issue":"3","key":"2026080410030260300_lvag131-B42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/EJE-19-0160","article-title":"Primary hyperparathyroidism with surgical indication and negative or equivocal scintigraphy: safety and reliability of PTH washout. A systematic review and meta-analysis","volume":"181","author":"Castellana","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026080410030260300_lvag131-B43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s40618-020-01482-4","article-title":"An update on non-thyroidal illness syndrome","volume":"44","author":"Fliers","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2026080410030260300_lvag131-B44","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1089\/thy.2014.0201","article-title":"Non-thyroidal illness in the ICU: a syndrome with different faces","volume":"24","author":"Van Den Berghe","year":"2014","journal-title":"Thyroid"},{"issue":"5","key":"2026080410030260300_lvag131-B45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1210\/er.2011-0007","article-title":"Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection","volume":"32","author":"Boelen","year":"2011","journal-title":"Endocr Rev"},{"issue":"10","key":"2026080410030260300_lvag131-B46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-8587(15)00225-9","article-title":"Thyroid function in critically ill patients","volume":"3","author":"Fliers","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2026080410030260300_lvag131-B47","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1210\/en.2013-2066","article-title":"A novel role for the thyroid hormone-activating enzyme type 2 deiodinase in the inflammatory response of macrophages","volume":"155","author":"Kwakkel","year":"2014","journal-title":"Endocrinology"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag131\/69963451\/lvag131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/R56\/69963451\/lvag131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/2\/R56\/69963451\/lvag131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:03:07Z","timestamp":1785852187000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/2\/R56\/8741572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag131","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,24]]}}}